Ahead of hosting our Carol concert in Liverpool this December, legendary British actor Dean Sullivan, known for playing lovable rogue Jimmy Corkhill in Brookside, speaks about his treatment and diagnosis.
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
BLOG: Dr Matthew Hobbs, our Acting Director of Research, shares his highlights from the latest research into more effective treatments for men with prostate cancer.
The National Institute for Health and Care Excellence has recommended pre-biopsy mpMRI scans and a host of other improvements to diagnosis and treatments for prostate cancer become standard NHS practice across the UK. While we back the proposals, we're calling for enough scanners and trained staff to deliver them.
We're funding Dr Alison Tree, an oncologist at the Royal Marsden, to trial a new kind of radiotherapy that keeps hormone therapy working for longer in men with advanced disease. She tells us about the cutting-edge technology behind the potential new treatment and the big hopes she has for it.
BLOG: Our research comms officer, Ruby Kell, explains how a promising new test we're funding could help identify men whose radiotherapy is likely to fail, then target them with a commonly-used drug that will stop the treatment from being thwarted.
More news from the National Cancer Research Institute (NCRI) Cancer Conference this week comes from researchers at the Institute of Cancer Research (ICR) in London. They’ve carried out a large-scale analysis of patient data from another trial to predict which men are most likely to experience unpleasant side effects after radiotherapy.
In this guest blog Dr Chris Armstrong – Marcher, Mo grower and ambitious researcher – explains what he hopes to achieve with the Travelling Prize Fellowship we’ve just awarded him and how this critical leg up the academic research ladder will benefit men with prostate cancer.
A type of radiotherapy that shapes radiation beams to tumors has grabbed headlines today. But more in-depth trials, already underway, are needed to give a clearer picture of the benefit for men.
Results from a 14-year radiotherapy study published today show that men can get the same benefit from a lower dose of radiotherapy with 17 fewer hospital visits.